Shimojani Overview

  • Founded
  • 2012
Founded
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

Shimojani General Information

Description

Developer of therapeutic drugs designed to reduce the risk of hemorrhagic conversion in stroke patients following a thrombolytic intervention. The company's drugs were found to validate and commercialize agents with the therapeutic potential, enabling ischemic stroke patients to reduce or prevent hemorrhagic conversion.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 158 Bridger Hollow Road
  • Pray, MT 59065
  • United States
+1 (650) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Shimojani Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 12-Jan-2021 Completed Out of Business
1. Early Stage VC Completed Startup
To view Shimojani’s complete valuation and funding history, request access »